Abstract: The invention relates to a method and apparatus (110) for receiving and displaying a stream of audiovisual information (200). During display of the stream of audiovisual information (200), the display may be interrupted by an application (220). This causes a user to miss part of the audiovisual information (200). It is therefore proposed to store the audiovisual information (200) during the application (220) and present the missed content (202) to the user after the interruption. The storage is automatically triggered by the start of the application (220). However, this causes a delay in the display of the audiovisual information (200). The user is offered the possibility to let the displayed stream of audiovisual information (210) catch up with the received audiovisual information (200). This catch-up may be performed automatically, triggered by the end of the application (220).

Abstract: An image display apparatus (400) for displaying a series (102) of consecutive output images (110-114) which are based on a series (100) of consecutive input images (104-108), with the series (100) of consecutive input images (104-108) comprising a first image (108) and a second image (106), is arranged to split the images (104-108) of the series (100) of consecutive input images (104-108) in first parts (128-132) and second parts (116-120); and to display a first one (112) of the output images (110-114) which comprises a first block of pixels (136) corresponding to a first one (132) of the first parts (128-132) of the first input image (108) and a second block of pixels (124) corresponding to a first one (118) of the second parts (116-120) of the second input image (106).

Abstract: A multi-protocol port interface coupled to a plurality of selectable circuits, each of the circuits being associated with an electrical interface standard and selectable via a mode-select input signal in order to facilitate communication with a peripheral device coupled to the port, the peripheral device having a circuit chosen from the plurality of selectable circuits and associated with an electrical interface standard.

Abstract: The present invention relates to a surfactant system and a consumable detergent composition comprising the same.

Abstract: A delivery system for uniform deposition of fabric care actives to a fabric article in a non-aqueous solvent based fabric treatment process; and compositions capable of uniformly depositing the fabric care actives on the fabric article being treated to achieve maximum benefit.

Abstract: A method for uniform deposition of fabric care actives to a fabric article in a non-aqueous solvent based fabric treatment process; and compositions capable of uniformly depositing the fabric care actives on the fabric article being treated to achieve maximum benefit.

Abstract: The present invention relates to compositions that can be used to provide lipophilic fluids with bleaching capabilities, lipophilic fluid cleaning compositions having bleaching capabilities and processes of making and using same. Such compositions provide the cleaning benefits of typical lipophilic solvents and additional cleaning benefits that include bleaching.

Abstract: The present invention relates to a composition and/or system comprising a perfume composition for use in a lipophilic fluid fabric treatment system and methods of making and using same. Such composition provides perfume/fabric substantivity.

Abstract: SOD and other active oxygen inhibitors are directly applied in combination with a barrier material at local sites of tissue injury to prevent or decrease formation of adhesions and undesirable proliferation of cells. Preferred barrier materials are polymeric hydrogels providing controlled release of AOI which are directly applied to the afflicted tissue. Examples demonstrate the effects of SOD on pelvic adhesions in the rat when administered by intraperitoneal (I.P.) bolus and by localized sustained release from a topically applied hydrogel system.

Abstract: The invention provides compositions and methods for treating a subject who has suffered from a central nervous system disorder. More particularly, the invention provides sustained polymeric drug delivery systems for direct delivery of therapeutic agents into the central nervous system.

Abstract: The present invention provides a method and a circuit for driving control electrodes between a reset voltage and an adjustable extraction voltage. The circuit includes a reset switch having first and second terminals with the first terminal being connected to a high voltage source. A plurality of set switches, each capable of assuming an on state and an off state connected such that a first terminal of each set switch is connected to a corresponding one of the control electrodes and a second terminal is connected to a low voltage source. The circuit further includes a plurality of diodes, each being connected between the second terminal of the reset switch and a corresponding one of the control electrodes.

Abstract: The present invention provides a method and circuit for driving control electrodes between a reset voltage and an adjustable control voltage. The circuit includes a reset switch capable of assuming a first state and a second state, the reset switch including a first terminal connected to a first voltage source; a plurality of diodes, each one of the plurality connected between a second terminal of the reset switch and a corresponding one of the control electrodes; and a plurality of voltage control switches, each voltage control switch being capable of assuming an active state and an inactive state, each voltage control switch including a first terminal connected to a corresponding one of the control electrodes and a second terminal connected to a second voltage source, wherein the extraction voltage supplied to a control electrode is adjusted by adjusting the length of time that the corresponding voltage source is made active.

Abstract: The present invention provides a method and circuit for driving control electrodes between a reset voltage and an adjustable control voltage. The circuit includes a reset switch capable of assuming a first state and a second state, the reset switch including a first terminal connected to a first voltage source; a plurality of diodes, each one of the plurality connected between a second terminal of the reset switch and a corresponding one of the control electrodes; and a plurality of voltage control switches, each voltage control switch being capable of assuming an active state and an inactive state, each voltage control switch including a first terminal connected to a corresponding one of the control electrodes and a second terminal connected to a second voltage source, wherein the extraction voltage supplied to a control electrode is adjusted by adjusting the length of time that the corresponding voltage source is made active.

Abstract: The present invention provides a method and a circuit for driving control electrodes between a reset voltage and an adjustable extraction voltage. The circuit includes a reset switch having first and second terminals with the first terminal being connected to a high voltage source. A plurality of set switches, each capable of assuming an on state and an off state connected such that a first terminal of each set switch is connected to a corresponding one of the control electrodes and a second terminal is connected to a low voltage source. The circuit further includes a plurality of diodes, each being connected between the second terminal of the reset switch and a corresponding one of the control electrodes.

Abstract: SOD and other active oxygen inhibitors are directly applied in combination with a barrier material at local sites of tissue injury to prevent or decrease formation of adhesions and undesirable proliferation of cells. Preferred barrier materials are polymeric hydrogels providing controlled release of AOI which are directly applied to the afflicted tissue. Examples demonstrate the effects of SOD on pelvic adhesions in the rat when administered by intraperitoneal (I.P.) bolus and by localized sustained release from a topically applied hydrogel system.

Abstract: A climate control system for a vehicle is disclosed, in which an air flow direction flap 34 is arranged in use to operate in accordance with a control quotient so as to present an air flow in a range of orientations. The orientations are arranged in groups which comprise base orientation levels 1, 2, 3, 4 and at least one group of intermediate orientation levels 110, 111; 220, 222; 330, 333 between two neighbouring said base orientation levels 1, 2, 3, 4. In moving between said neighbouring base orientation levels 1, 2, 3, 4, said air flow directing flap 34 passes, at least transiently, through substantially each said intermediate orientation level 110, 111; 220, 222; 330, 333, whereby a variation in said presentation of said air flow A/F between said neighbouring base orientations appears to a user to be more gradual than would be a substantially stepped change if made directly therebetween.

Abstract: A climate control arrangement in which an existing automatic climate control system is adapted by an indicator quotient (TOA). A controller adjusts air duct distribution so that differential proportions of air flow can be presented to fixed air duct vents at respective height level HL, FL relative to an occupant of a motor vehicle. The indicator quotient (TAO) being determined by appropriate comparison of objective temperature, actual temperature and environmental temperature and is used by the controller for consistent occupant preferred air flow distribution between normal conditions and more extreme environmental conditions. Thus, occupant preferences for air flow distribution in normal Spring or Autumn type environmental conditions are adapted for more extreme Winter and Summer conditions without iterative and constant variation by that occupant.

Abstract: A device for providing an RF signal burst to an external load includes a voltage-controlled oscillator to generate a drive signal having a frequency f.sub.VCO fixed by an oscillator control signal. An RF driver stage coupled to the external load receives the drive signal and generates an RF signal burst in response to the drive signal. A current transformer coupled between the RF driver stage and the external load senses the current in the RF driver stage and generates a reference current having the same phase as the sensed current. A phase detector receives the reference current along with the drive signal and generates a phase detection signal that provides a measure of the phase of the current in the RF driver stage with respect to the drive signal. The phase detection signal can be used to adjust the oscillator control signal to drive the oscillator frequency to a desired value.

Abstract: The heating feeling of an occupant is improved by setting the optimum time for a bi-level mode. A controller (7) switches an outlet mode to a FOOT/FACE mode (bi-level mode) if the water temperature (temperature of engine cooling water) rises to 45.degree. C. or higher in the course of warm-up control, and the necessary blowing temperature TAO is not lower than 100.degree. C. In the FOOT/FACE mode, the setting time (timer time) is variable depending on the outside air temperature and the presence/absence of solar radiation. Specifically, setting is done so that the lower the outside air temperature, the longer the timer time, and the higher the outside air temperature, the shorter the timer time. When solar radiation is present, the timer time is corrected in accordance with the time at which it is judged that solar radiation is present.

Abstract: A method for universally distributing a therapeutic agent, in an encapsulated form, to the brain of a subject using intrathecal administration, excluding the lumbar region, is described. Methods for treating stroke and/or Traumatic Brain Injury (TBI) are also described. The methods involve intrathecal administration into the cerebrospinal fluid of a subject, of a therapeutic agent in an encapsulated form. Pharmaceutical compositions intended for the amelioration of stroke and/or Traumatic Brain Injury (TBI) are also described. The pharmaceutical compositions comprise a therapeutic agent encapsulated in a pharmaceutically acceptable polymer, suitable for injection into the cerebrospinal fluid of a subject suffering from stroke and/or Traumatic Brain Injury (TBI).